Cargando…

Acute Uncomplicated UTI and E. coli Resistance: Implications for First-Line Empirical Antibiotic Therapy

BACKGROUND: Uncomplicated urinary tract infection (uUTI) typically affects immunocompetent, anatomically normal women. Escherichia coli (E. coli) accounts for approximately 80% of cases. Given increased E. coli-trimethoprim sulfamethoxazole (TMP-SMX) resistance, practice guidelines advocate first-li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perfetto, Eleanor M, Keating, Karen, Merchant, Sanjay, Nichols, Brian R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2004
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437401/ https://www.ncbi.nlm.nih.gov/pubmed/14720102 http://dx.doi.org/10.18553/jmcp.2004.10.1.17

Ejemplares similares

Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period
por: van Driel, A. A., et al.
Publicado: (2019)

Treatment of uncomplicated UTI in males: a systematic review of the literature
por: Farrell, Karen, et al.
Publicado: (2021)

Empiric versus culture-based antibiotic therapy for UTIs in menopausal women
por: Kusin, Samuel B., et al.
Publicado: (2023)

1433. Impact of 2019 US Food and Drug Administration (FDA) Guidance on Developing Drugs for Urinary Tract Infection (UTI) on the Perceived Efficacy of Antibiotics for the Treatment of Uncomplicated UTI (uUTI)
por: Henriksen, Anne Santerre, et al.
Publicado: (2021)

2238. Estimating the impact of antibiotic exposure on antibiotic resistance in uncomplicated UTI using machine learning causal inference
por: Kanjilal, Sanjat, et al.
Publicado: (2022)

1425. Revisiting β-Lactams for Treatment of Uncomplicated Urinary Tract Infections: Evaluation of Twice-daily Cephalexin for Empiric Treatment of UTIs
por: Benning, Molly, et al.
Publicado: (2021)

Is it possible to extrapolate the rates of resistance of Escherichia coli from asymptomatic bacteriuria in pregnant women to those of E. coli in uncomplicated community-acquired UTI?
por: Asenjo, Alejandra, et al.
Publicado: (2019)

1471. Medical Claims Analysis as a Tool to Evaluate Empiric and Targeted Antibiotic Therapy in UTIs
por: Hui, Wing, et al.
Publicado: (2019)

Different recommendations for empiric first-choice antibiotic treatment of uncomplicated urinary tract infections in Europe
por: McQuiston Haslund, Josephine, et al.
Publicado: (2013)

Retrospective study of men with E. coli UTI treated with an oral antibiotic, and risk for a new prescription or hospital admission due to UTI
por: Jansåker, Filip, et al.
Publicado: (2020)

Recurrent Urinary Tract Infections: Unraveling the Complicated Environment of Uncomplicated rUTIs
por: Josephs-Spaulding, Jonathan, et al.
Publicado: (2021)

147. Pharmacist Attitudes Towards Using Clinical Decision Support in Community Pharmacies to Promote Antibiotic Stewardship in the Treatment of Uncomplicated UTI
por: Sayood, Sena, et al.
Publicado: (2020)

Susceptibility pattern of oral antimicrobials in uncomplicated UTI: Does fosfomycin still stand effective?
por: Batra, Priyam, et al.
Publicado: (2020)

Effects of an optimised POCT guided diagnostic and treatment strategy for symptoms of uncomplicated UTI on use of appropriate antibiotics and uptake into primary care practice
por: Bates, Janine, et al.
Publicado: (2013)

Does prophylactic antibiotics post pediatric pyeloplasty reduce the incidence of febrile UTIs?
por: Sheth, Kunj, et al.
Publicado: (2023)

Etiology of UTI – pathogens involved and their sensitivity to antibiotics
por: Carp, Sorina, et al.
Publicado: (2014)

2222. 3-Day Ceftriaxone vs. Longer Durations of Therapy For Inpatient Treatment of Uncomplicated UTI 
por: Elajouz, Balsam, et al.
Publicado: (2022)

P16 UTI Friday: a review of antibiotic prophylaxis in the management of recurrent UTI in primary care
por: Tucker, Avril
Publicado: (2023)

Asymptomatic Bacteriuria Escherichia coli Are Live Biotherapeutics for UTI
por: Rudick, Charles N., et al.
Publicado: (2014)

2824. 3rd Generation Cephalosporin (3rd CEP) Use and Antibiotic Selection Appropriateness for Uncomplicated Febrile Urinary Tract Infections (UTI) in Children
por: Dantas, Marina, et al.
Publicado: (2023)

Co-Amoxiclav as empiric treatment of UTI in children: importance of surveillance in ensuring optimal empiric treatment choice
por: Trayer, James, et al.
Publicado: (2021)

Patterns of recurring dispensing of guideline antibiotics for uncomplicated urinary tract infection in women over a 5-year period: Longitudinal patterns of recurring dispensings of Dutch guideline UTI antibiotics
por: Lelie- van der Zande, Rian C, et al.
Publicado: (2020)

Antibiotic resistance of E. coli isolates from urine samples of Urinary Tract Infection (UTI) patients in Pakistan
por: Jafri, Saghir Ahmad, et al.
Publicado: (2014)

42. INSPIRE-ASP UTI Trial: A 59 Hospital Cluster Randomized Evaluation of INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection versus Routine Antibiotic Selection Practices for Patients with Urinary Tract Infection (UTI)
por: Gohil, Shruti K, et al.
Publicado: (2021)

COSUTI: A Core Outcome Set (COS) for Interventions for the Treatment of Uncomplicated Urinary Tract Infection (UTI) in Adults
por: Beecher, Claire, et al.
Publicado: (2022)

Understanding patient and clinician perspectives of antibiotic use for the treatment of UTIs
por: Hannum, Susan, et al.
Publicado: (2020)

1475. Understanding Prescribing Practices for Uncomplicated Urinary Tract Infections (UTIs) in the Primary Care Setting: A Pilot Study
por: Pinkerton, Mark, et al.
Publicado: (2019)

1330. Development of a Pediatric Emergency Department (ED) Uropathogen Antibiogram and Empiric Urinary Tract Infection (UTI) Treatment Algorithm
por: Dass, Akshith M, et al.
Publicado: (2020)

Sequencing of E. coli strain UTI89 on multiple sequencing platforms
por: Fenlon, Shannon N., et al.
Publicado: (2020)

Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study
por: Abongomera, George, et al.
Publicado: (2021)

Assessing clinical cure of empirical piperacillin/tazobactam for ESBL urinary tract infections (ACCEPT—UTI)
por: Stefanos, Sylvia S, et al.
Publicado: (2023)

1453. Cephalexin and Cefadroxil Are Not Therapeutic Equivalents for Uncomplicated Cystitis (uUTI): Further Analysis of Cefazolin Surrogate Susceptibility Testing Criteria
por: Jones, Ronald N, et al.
Publicado: (2019)

1428. Increased Consumption of Pivmecillinam in Primary Care for Uncomplicated Urinary Tract Infection (uUTI) Is Not Associated With Increased Resistance Rates
por: Larsen, Anders Rhod, et al.
Publicado: (2021)

Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study
por: Aypak, Cenk, et al.
Publicado: (2009)

Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated Cystitis
por: Zhanel, George G., et al.
Publicado: (2016)

COSUTI: a protocol for the development of a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults
por: Duane, Sinead, et al.
Publicado: (2019)

The Improving Outcomes of UTI Management in Long-Term Care Project (IOU) Consensus Guidelines for the Diagnosis of Uncomplicated Cystitis in Nursing Home Residents
por: Nace, David A., et al.
Publicado: (2018)

UTI myths and misconceptions
Publicado: (2020)

1508. Urinary Tract Infections (UTIs) in the First Year Post-Renal Transplant: Risks and Opportunities
por: Bohn, Brian, et al.
Publicado: (2018)

UTI detection by PCR: Improving patient outcomes
por: Kelly, Brian N.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l3vjo1m2nh5d16vakeflj17o6s